Open letter raises concerns about NICE guidance on statins

@article{Wise2014OpenLR,
  title={Open letter raises concerns about NICE guidance on statins},
  author={Jacqui Wise},
  journal={BMJ : British Medical Journal},
  year={2014},
  volume={348}
}
  • J. Wise
  • Published 11 June 2014
  • Medicine
  • BMJ : British Medical Journal
A group of leading doctors have written an open letter to David Haslam, chairman of the National Institute for Health and Care Excellence (NICE), and to the health secretary, Jeremy Hunt, raising serious concerns about the latest draft guidance on statins.1 The letter was signed by Richard Thompson, president of the Royal College of Physicians, and Clare Gerada, former chairwoman of the Royal College of General Practitioners. The letter said, “We urge you to withdraw the current guidance on… 
NICE sticks to its advice to drop threshold for prescribing statins
  • N. Hawkes
  • Medicine
    BMJ : British Medical Journal
  • 2014
TLDR
The group responsible for recommending the wider use of statins had faced “completely unjustified attacks on their integrity,” the director of the National Institute for Health and Care Excellence (NICE) complained at a press conference to launch the final version of the guidance.
Impact of lowering the risk threshold for statin treatment on statin prescribing: a descriptive study in English primary care
TLDR
The proportion of people initiating statins that had a coded risk score in their medical record increased significantly from 2010–2017, and currently available evidence indicates the guideline change had a large impact on statin prescribing.
Cohort study investigating the relationship between cholesterol, cardiovascular risk score and the prescribing of statins in UK primary care: study protocol
TLDR
This research will establish how cholesterol levels and CVD risk independently influence the prescribing of statins for the primary prevention of CVD in primary care.
Statin initiations and QRISK2 scoring in UK general practice: a THIN database study.
  • S. Finnikin, R. Ryan, T. Marshall
  • Medicine
    The British journal of general practice : the journal of the Royal College of General Practitioners
  • 2017
TLDR
The relationship between CVD risk scoring in primary care and initiation of statins for the primary prevention of CVD, and the effect of changes to the National Institute for Health and Care Excellence (NICE) guidance in 2014 are investigated.
Cost-effectiveness of the polypill versus risk assessment for prevention of cardiovascular disease
TLDR
Although less restrictive risk assessment and polypill scenarios prevented more CVD events and attained larger survival gains, these benefits were offset by the additional costs and disutility of daily medication use.
Beyond ten-year risk : novel approaches to the primary prevention of cardiovascular disease
TLDR
This thesis shows that standard care regarding the primary prevention of CVD often ignores heterogeneity, leading to suboptimal decision-making, and holds true for long-established, inexpensive treatments like statin therapy and novel, expensive treatments like PCSK9 inhibitors.
Statins for all? A question for society
  • D. Barer
  • Medicine
    BMJ : British Medical Journal
  • 2014
The debate about extending the use of statins to those with an (unreliably) estimated 1% annual risk of cardiovascular disease is degenerating into an unseemly row about side effects,1 2 3 largely
The Disparate Approaches of General Practitioners to the Pharmaceuticalisation of Cardiovascular Disease Prevention
TLDR
The paper argues that the way GPs approach CVD pharmaceuticalisation is shaped by their understandings of and use of guidelines, existing treatment perspectives and the moral qualities of preventative treatment, and professional evaluations of 'relevant’ information.
Effect of Statins use on Cardiac, Diabetes, Kidney and Liver Function – An update
TLDR
Among the statins used, atorvastatin was found to be very beneficial with minimal side effects with greater beneficial function in maintaining other organ functions and some merits shown in the use of statins include prevention of MCI and strokes.
Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease
TLDR
Generic pricing has rendered preventive statin therapy cost-effective for many adults and absolute risk reduction (ARR)–guided therapy is more effective than 10-year risk scoring and is cost- effective.
...
1
2
3
...

References

NICE recommends wider use of statins in draft guidelines
  • J. Wise
  • Medicine
    BMJ : British Medical Journal
  • 2014
TLDR
Draft guidance from the National Institute for Health and Care Excellence recommends that doctors use the QRISK2 assessment tool to identify people aged 40-74 who are likely to be at high risk of developing cardiovascular disease.